The US, in partnership with COVAX, has provided more than 2.8 million additional life-saving doses of the Pfizer-BioNTech vaccine to Vietnam.  

It was the latest announcement by the US Embassy in Hanoi on November 8.

The arrival of over 1.3 million doses of Pfizer vaccine on November 6 in Hanoi. Photo: The US Embassy in Hanoi

Among these vaccines, over 1.3 million doses arrived on November 6 in Hanoi, and two shipments of more than 1.5 million doses arrived on November 7 and 8 in Ho Chi Minh City. This is the seventh delivery to Vietnam, totaling more than 15 million Covid-19 vaccine doses made available by the US, the statement noted.

The US has committed more than $30.2 million in Covid-19 related assistance for Vietnam since the beginning of the pandemic. 

“Building on our longstanding cooperation and investment in Vietnam’s health infrastructure, we have provided support to essentially every pillar of the country’s pandemic response,” the US Embassy in Hanoi said.

“From virtual trainings that have reached thousands of hospital workers, to genetic sequencing technology that allows Vietnam to track variants of the virus, to equipment for testing and for vaccine storage, to life-saving equipment, such as ventilators, oxygen concentrators, and liquid-oxygen tanks for patients in need. We stand shoulder-to-shoulder with Vietnam in the fight against Covid-19," the statement wrote.

At the Global Covid⁠19 Summit on September 22, the US President announced a commitment to provide an additional 500 million Pfizer doses to 92 low- and middle-income countries and economies around the world, and the African Union, bringing the US total global commitment to more than 1.1 billion doses.

Vietnam has been a leading recipient of these doses, according to the US Embassy in Hanoi.  

The US has provided more than 220 million doses of Covid-19 vaccines to more than 100 countries and economies around the world. The US Mission to Vietnam will continue to provide additional vaccine doses globally as supply becomes available. 

They are also working with US vaccine manufacturers to increase vaccine supply for the rest of the world and with partners to expand global vaccine production and manufacturing capacity to beat this pandemic.